Skip to main content

Un programa de rehabilitación hace que los pacientes vuelvan a sus trabajos más pronto

La discapacidad se acorta con una atención integrada, según una investigación

MIÉRCOLES, 17 de marzo (HealthDay News/DrTango) -- Un estudio reciente sugiere que las personas que tienen dolor crónico en la espalda baja que las mantiene alejadas de sus puestos de trabajo pueden recuperarse cuatro meses antes en promedio si participan en un programa de rehabilitación de un tipo específico.

Investigadores de los Países Bajos y Canadá estudiaron a 134 pacientes de dolor crónico en la espalda baja que no habían podido ir a trabajar por cerca de seis meses, en promedio. Los pacientes, de 18 a 85 años, fueron asignados de manera aleatoria para recibir atención habitual o formar parte de un programa llamado "atención integrada".

El programa de atención integrada incluía ajustes en el ambiente de trabajo y un programa de ejercicio que enseñaba a los pacientes a moverse de forma segura y a ser más activos.

Durante un año, los pacientes que formaron parte del programa de atención integrada volvieron a sus puestos de trabajo en un promedio de 88 días en comparación con 208 días de los que recibieron la atención habitual, de acuerdo con el informe que aparece en línea el 17 de marzo en BMJ.

Aunque no hubo diferencias estadísticamente significativas entre los grupos en cuanto a los niveles reportados de mejoras en el dolor, los autores del estudio apuntaron que el programa de atención integrada mejoró de forma significativa el estado funcional de los pacientes y redujo su discapacidad tanto en el hogar como en el lugar de trabajo.


Artículo por HealthDay, traducido por Hispanicare
http://www.nlm.nih.gov/medlineplus/spanish/news/fullstory_96527.html
FUENTE: BMJ, news release, March 17, 2010

HealthDay
Labels:

Comments

  1. AnonymousMar 22, 2010, 10:31:00 AM

    Los profesionales de la salud somos férreos defensores de la educación para la salud, es muy importante que se divulguen los trabajos cientificos en esta área. Siempre excelentes tus artículos Carlos!
    Buena semana y saludos ergonómicos!
    Silvia López Senés- Ergoffice

    ReplyDelete

Post a Comment

Popular posts from this blog

Light Therapy holds promise as a treatment for Alzheimer's Disease

A new article, conducted by Lili Zang and colleagues from Weifang Medical University School of Nursing in Shandong Province, China, discusses a meta-analysis of 15 high-quality trials that investigated the impact of light therapy on individuals with Alzheimer’s disease (AD). The meta-analysis included 598 patients with mild to moderate Alzheimer’s disease, and it covered 15 randomized controlled trials conducted in seven different countries. Those trials were published between 2005 and 2022. Sleep Improvement Light therapy led to significant improvements in several sleep measures. It notably enhanced sleep efficiency, increased interdaily stability, and reduced intradaily variability, all of which are indicators of better sleep quality. Light therapy was associated with a reduction in agitation, depression, and caregiver burden among individuals with Alzheimer’s disease. A significant advantage over usual care was shown in reducing the severity of psychobehavioral symptoms, as assessed
Post a Comment
See more...

Carvacrol: Health benefits from aromatic herbs (oregano, thyme)

Carvacrol is a phenolic monoterpenoid found in various essential oils. Oregano, thyme, and bergamot contain carvacrol. It boasts a range of beneficial properties for potential clinical applications. This compound has shown antimicrobial, antioxidant, and anticancer activities. It showed antimicrobial efficacy against food-borne pathogens like Escherichia coli and Salmonella. It is attributed to a unique combination of its chemical characteristics. Carvacrol, often used alongside thymol (another phenolic monoterpenoid found in these oils), exhibits high antioxidant activity and has been employed as a dietary additive to enhance the antioxidant status in animals (I.E. in poultry nutrition) Preclinical studies suggest promising anticancer properties of carvacrol, particularly in breast, liver, and lung carcinomas, through (proapoptotic) mechanisms involving elimination of DNA abnormalities. However, despite a well-defined toxicological profile, the lack of human trials hinders conclusive
Post a Comment
See more...

Obesity, Zinc supplement and cognitive function

  In a recent study, researchers were concerned about the impact of obesity on cognitive health,  Even knowing that obesity is linked to cognitive decline and problems with the brain, they investigated if giving overweight or obese women a zinc supplement could help. In the study participated 42 women aged 40 to 60 and were splitted into two groups. One group received a zinc supplement (30 mg per day), while the other received placebo, for 12 weeks. Information about these women, like age, weight, diet, and physical activity was collected. To measure cognitive function and mood, various tests and questionnaires were used. They also checked certain substances in women's saliva to understand what was happening in their bodies. The results showed that the women who took the zinc supplement had better scores in cognitive tests, even though they didn't lose weight.  This suggests that taking zinc might help overweight or obese women maintain better cognitive function, regardless of
Post a Comment
See more...